Genprex

Investor

Downloads


Investor Presentation

Review our latest corporate presentation with an overview of company highlights, recent milestones and clinical updates.

Download

2022 Genprex Shareholder Letter

Read Genprex’s 2022 Shareholder Letter and Corporate Update

Download

Fact Sheet

A one-page fact sheet and overview of Genprex.

Download

TUSC2 Bibliography

A bibliography of selected publications describing the TUSC2 gene.

Download

PDX1 and MAFA Bibliography

A bibliography of selected publications describing the PDX1 and MAFA genes.

Download

2021 AACR Poster – Overcoming resistance to osimertinib by TUSC2 gene therapy in EGFR mutant NSCLC – Meraz

The poster presents positive preclinical data for REQORSA in combination with Tagrisso®, demonstrating synergistic antitumor efficacy in EGFR mutant Tagrisso resistant NSCLC tumors in H1975-OsiR isogenic tumors. Researchers also found that the upregulation of PDK1 was associated with osimertinib resistance.

Download

2020 International Journal of Molecular Sciences

The study found TUSC2 may be a novel target and biomarker for thyroid cancer therapy.

Download

2019 AACR KRAS and LKB1 Poster – Meraz

The poster demonstrates research and data on the efficacy of novel immunogene combinations for KRAS and LKB1 mutant NSCLC in a humanized mouse model.

Download

2019 Nature Research Scientific Reports

The study found that TUSC2 prevented tumor growth in triple-negative breast cancer (TNBC), which is currently considered an incurable cancer with limited therapeutic options.

Download

2019 AACR Hu-PDX Poster – Meraz

The poster presents positive preclinical data for the combination of the TUSC2 gene with an anti-PD1 antibody, pembrolizumab, for the treatment of lung cancer in a humanized mouse model.

Download

2012 AACR Poster – Yan

The poster describes a novel anticancer therapeutic strategy using a new class of rationally designed dual DNA alkylating/HDAC inhibitors combined with nanoparticle-mediated gene therapy targeting the DNA damage/repair pathway in human NSCLC and SCLC cells.

Download

2012 AACR Poster – Meng

The poster presents data on the synergistic antitumor activity of MK2206 and TUSC2/FUS1-nanoparticle in NSCLC.

Download